What’s New in Lung Cancer?
This course provides healthcare professionals with an in-depth understanding of the latest advancements in lung cancer, including the most recent approaches to diagnosis, screening, and treatment. With a focus on precision medicine, molecular profiling, and immunotherapy, this course aims to empower clinicians with the knowledge needed to apply the latest research and best practices in managing lung cancer patients. Participants will also learn about personalized treatment strategies, advancements in early detection, and how to improve patient outcomes through comprehensive care.
.jpg)
Learning Outcomes
What you'll learn
- Understand the latest trends and advancements in lung cancer diagnosis and treatment.
- Identify key genetic mutations and their role in personalized treatment strategies.
- Discuss how immunotherapies and targeted treatments are changing the landscape of lung cancer care.
- Evaluate current lung cancer screening methods and their effectiveness in early detection.
- Recognize the challenges in treating advanced lung cancer and enhancing patient survival.
- Apply new guidelines and research findings in clinical practice for better patient management.
Stay updated with our


Learning Outcomes
What you'll learn
- Understand the latest trends and advancements in lung cancer diagnosis and treatment.
- Identify key genetic mutations and their role in personalized treatment strategies.
- Discuss how immunotherapies and targeted treatments are changing the landscape of lung cancer care.
- Evaluate current lung cancer screening methods and their effectiveness in early detection.
- Recognize the challenges in treating advanced lung cancer and enhancing patient survival.
- Apply new guidelines and research findings in clinical practice for better patient management.
Stay updated with our


Training Overview
- Introduction to Lung Cancer – Key Insights and Recent Trends
- Lung Cancer Screening – Modern Approaches and Guidelines
- The Role of Molecular Profiling in Lung Cancer
- Immunotherapy – A Breakthrough in Lung Cancer Treatment
- Managing Side Effects and Quality of Life in Lung Cancer Patients
- Lung Cancer Research and Treatment
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
Top reviews
No reviews yet.
You May Also Like
Are you a qualified
Trainer or Instructor?
Join Care Learning as a trainer and deliver high-quality courses to learners across healthcare and workplace training.
Refer a Friend &
Earn Rewards.
Invite healthcare professionals to join Care Learning and get rewarded when your referral successfully joins.
Frequently asked questions
Lung cancer is mainly categorized into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), with NSCLC being the more common form.
Molecular profiling identifies genetic mutations in tumor cells, which helps to select targeted therapies, improving the effectiveness of treatment and reducing unnecessary side effects.
Immunotherapy helps the immune system to identify and destroy cancer cells. It is particularly effective for patients with advanced stages of lung cancer and has been shown to improve survival rates.
Early detection through screening leads to a higher chance of successful treatment and can significantly reduce mortality rates by identifying lung cancer at an earlier, more treatable stage.
A liquid biopsy is a blood test that detects cancer-related genetic mutations and can be used for monitoring treatment response or identifying relapsed cancer in a less invasive way than traditional tissue biopsies.
Targeted therapies focus on specific genetic mutations in the cancer cells, targeting them directly and interrupting the pathways that allow cancer cells to grow and divide.
.jpg)
.jpg)
.jpg)



